scispace - formally typeset
D

David A. Kass

Researcher at Johns Hopkins University School of Medicine

Publications -  605
Citations -  63963

David A. Kass is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 127, co-authored 580 publications receiving 58747 citations. Previous affiliations of David A. Kass include University of Pittsburgh & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence.

TL;DR: It is revealed that DAF-2 can assess real-time SS-stimulated NO synthesis in endothelial cells and facilitate the analysis of NO-signaling pathways, providing novel insights into several NO signaling determinants.
Journal ArticleDOI

TRP-ing up heart and vessels: canonical transient receptor potential channels and cardiovascular disease.

TL;DR: New evidence supporting a pathophysiologic role of these three TRPC channels is described, and the potential utility of inhibition strategies to treat cardiovascular disease is described.
Journal ArticleDOI

Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy

TL;DR: Enalaprilat attenuates beta-adrenergic contractility and enhances left ventricular distensibility in patients with idiopathic dilated cardiomyopathy, but not in subjects with normalleft ventricular function.
Journal ArticleDOI

Pressure-volume analysis of changes in cardiac function in chronic cardiomyoplasty

TL;DR: Assessment of the primary functional properties of the heart wrapped by conditioned muscle using pressure-volume relation analysis based on conductance catheter volume data concludes that in the nonfailing heart, increased contractility does not augment cardiac output, ejection fraction, and stroke work because of a simultaneous decrease in end-diastolic volume.
Journal ArticleDOI

Peroxynitrite and myocardial contractility: in vivo versus in vitro effects.

TL;DR: Systemic generation of ONOO- is unlikely to have primary cardiac effects, but may modulate cardiac contractile reserve, via blunted beta-adrenergic stimulation, and vascular tone, as a result of generation of NO2- and NO3-.